UA131890U - METHOD OF TREATMENT OF COMORBIDE BACTERIAL INFECTIONS IN PATIENTS WITH CHRONIC DISEASE IN STAGE - Google Patents
METHOD OF TREATMENT OF COMORBIDE BACTERIAL INFECTIONS IN PATIENTS WITH CHRONIC DISEASE IN STAGEInfo
- Publication number
- UA131890U UA131890U UAU201806641U UAU201806641U UA131890U UA 131890 U UA131890 U UA 131890U UA U201806641 U UAU201806641 U UA U201806641U UA U201806641 U UAU201806641 U UA U201806641U UA 131890 U UA131890 U UA 131890U
- Authority
- UA
- Ukraine
- Prior art keywords
- patients
- bacterial infections
- treatment
- stage
- comorbide
- Prior art date
Links
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Спосіб лікування коморбідних бактеріальних інфекцій у хворих на хронічну хворобу нирок VД стадії включає проведення комплексної терапії із застосуванням антибактеріального лікування та лікарського засобу Ліпін з визначенням ефективності способу. Антибактеріальну терапію проводять з урахуванням локалізації інфекційного процесу та лікарського засобу Ліпін внутрішньовенно в дозі 500 мг 1 раз на добу, щоденно, протягом 10 днів, а ефективність способу визначають як за оцінкою показників стану оксидантно-антиоксидантної системи, так і клінічній оцінці перебігу бактеріальної інфекції у хворих, які лікуються діалізними методами нирково-замісної терапії.A method of treating comorbid bacterial infections in patients with chronic kidney disease VD stage involves carrying out complex therapy with the use of antibacterial treatment and the drug Lipin to determine the effectiveness of the method. Antibacterial therapy is carried out taking into account the localization of the infectious process and the drug Lipin intravenously at a dose of 500 mg once a day, daily, for 10 days, and the effectiveness of the method is determined by assessing the status of the oxidant-antioxidant system and clinical assessment of bacterial infection patients treated with dialysis renal replacement therapy.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UAU201806641U UA131890U (en) | 2018-06-13 | 2018-06-13 | METHOD OF TREATMENT OF COMORBIDE BACTERIAL INFECTIONS IN PATIENTS WITH CHRONIC DISEASE IN STAGE |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UAU201806641U UA131890U (en) | 2018-06-13 | 2018-06-13 | METHOD OF TREATMENT OF COMORBIDE BACTERIAL INFECTIONS IN PATIENTS WITH CHRONIC DISEASE IN STAGE |
Publications (1)
Publication Number | Publication Date |
---|---|
UA131890U true UA131890U (en) | 2019-02-11 |
Family
ID=65576933
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAU201806641U UA131890U (en) | 2018-06-13 | 2018-06-13 | METHOD OF TREATMENT OF COMORBIDE BACTERIAL INFECTIONS IN PATIENTS WITH CHRONIC DISEASE IN STAGE |
Country Status (1)
Country | Link |
---|---|
UA (1) | UA131890U (en) |
-
2018
- 2018-06-13 UA UAU201806641U patent/UA131890U/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR109103A1 (en) | TREATMENT OF FABRY'S DISEASE IN PATIENTS NOT TREATED AND PREVIOUSLY TREATED WITH ERT | |
ATE490470T1 (en) | THERAPY PROCEDURES | |
EA201491460A1 (en) | APPLICATION OF LACHINIMODA IN THE TREATMENT OF PATIENTS WITH CRONE'S DISEASE, WHICH ARE NOT EFFECTIVE THERAPY OF THE FIRST LINE ANTI-TNFα | |
BR112021018815A2 (en) | Gepotidacin for use in the treatment of bacterial urinary tract infections | |
PH12020551905A1 (en) | C-mannoside compounds useful for the treatment of urinary tract infections | |
JP2016501219A5 (en) | ||
WO2018020285A3 (en) | Flow capture device and method for removing cells from blood | |
UA131890U (en) | METHOD OF TREATMENT OF COMORBIDE BACTERIAL INFECTIONS IN PATIENTS WITH CHRONIC DISEASE IN STAGE | |
RU2012151952A (en) | METHOD FOR CREATING PLEUROSIS | |
EA202091653A1 (en) | MINOCYCLINE FOR THE TREATMENT OF INFLAMMATORY SKIN DISEASES | |
DK2037949T3 (en) | Process for preparing a "transfer factor" drug | |
RU2585097C1 (en) | Method of treating chronic pancreatitis | |
RU2675692C1 (en) | Method of mycobacterium tuberculosis exposing in vitro experiment | |
RU2602954C1 (en) | Agent for treating chronic inflammatory diseases of urethra and bladder | |
UA116487C2 (en) | METHOD OF TREATMENT OF PUSH-INFLAMMATORY PROCESSES BY ANTIMicrobials | |
BR112023024354A2 (en) | ESSENTIAL TREMOR TREATMENT METHOD | |
UA129745U (en) | METHOD OF TREATMENT OF PATIENTS WITH Bronchial Asthma With Ischemic Heart Disease | |
RU2295341C1 (en) | Method for treating tuberculous pleurisy cases | |
EA202192612A1 (en) | CANAGLIFLOSIN FOR THE TREATMENT OF DIABETES PATIENTS WITH CHRONIC KIDNEY DISEASE | |
Gharibian et al. | Cefepime dosing in modeled critically Ill patients receiving SHIFT hemofiltration or hemodialysis renal replacement therapies | |
RU2009117809A (en) | METHOD FOR TREATING VAGINAL INFECTIONS | |
RU2008138024A (en) | METHOD FOR TREATING ACUTE FORMS OF BACTERIAL VAGINITES | |
UA102543U (en) | METHOD OF TREATMENT OF PYELONEPHRITIS IN PATIENTS WITH URINARY STONE DISEASE AFTER DISTANCE SHOCK-WAVE LITOTRIPY | |
UA60092U (en) | A method for treating patients with scleroderma | |
Kinoshita | Linezolid/warfarin interaction |